Mateon Therapeutics to initiate commercialization of COVID-19 Ayurveda med in India
Mateon Therapeutics has announced that ArtiShield is now approved for manufacture and marketing by the Ministry of AYUSH, for the treatment of various symptoms like fever and inflammation. ArtiShield is in co-development with Windlas Biotech, Mateon’s commercial partner for India.
By Team Ayurved Sutra
Posted on
